Carbohydrate polymers
Cure8 research brief
Why This Matters
Researchers identified a defined pectin from Sanguisorba officinalis that reduced inflammatory cytokine release in cells and improved outcomes in a mouse colitis model, suggesting a new lead for IBD drug discovery.
Who Should Pay Attention
Researchers in IBD drug discovery, clinicians following experimental therapies, and patients interested in preclinical natural-product research.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This paper reports the isolation and structural characterization of a pectin (named 147-02-S2) from roots of Sanguisorba officinalis and tests its anti-inflammatory activity in cells and a mouse model of DSS-induced colitis. In vitro, the compound reduced LPS-stimulated TNF-α and IL-1β release from human colonic NCM460 cells.
In vivo, the authors report that 147-02-S2 alleviated symptoms in mice with dextran sulfate sodium (DSS)–induced colitis and inhibited signaling pathways (TLR4/MyD88, p38/ERK, and NF-κB) linked to cytokine production.
The study is presented as a preclinical, mechanistic investigation and identifies 147-02-S2 as a potential lead for further drug discovery rather than a tested therapy for people. The work combines chemical structural analysis with cell-culture and mouse experiments to support a biological effect.
Keep In Mind
Findings come from in vitro and DSS mouse model experiments reported in the article abstract; they do not indicate clinical benefit in people. The structured content depth is abstract, so the brief is grounded in the source-provided abstract.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationCarbohydrate polymers
AuthorsLi S, Wu L, Wang T +5 more
Study typeJournal article
Indexed viaEurope PMC
Source typeResearch paper
PublishedJun 2, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Changyanqing decoction ameliorates ulcerative colitis via PI3K-Akt pathway: Insights from network pharmacology and in-vitro validation.
Patients and clinicians often ask whether herbal formulas or plant compounds can help IBD. This preclinical study identifies quercetin and the PI3K–Akt pathway as potential mechanisms, which may guide future research...
Cyanidin‐3‐O‐glucoside Alleviates Inflammatory Bowel Disease by Targeting the NF‐κB Pathway and is Associated With Alterations in 1‐DNJ
A natural compound (C3G) reduced inflammation and changed gut bacteria and metabolites in an experimental colitis model, pointing to possible new mechanisms or leads for IBD therapies.
Arctigenin, a Lignan Ingredient in Burdock, Inhibits Gasdermin D-Mediated Pyroptosis of Colonic Macrophages to Alleviate Ulcerative Colitis by Down-Regulating Fatty Acid Oxidation.
The study identifies a cellular mechanism by which arctigenin reduced inflammatory macrophage death and improved colitis in mice, suggesting a potential new target (macrophage FAO → GSDMD) for therapies or...